Ukraine’s Plea To Industry: Restart Clinical Trials And Give Us New ‘Weapons’ To Fight Cancer

While Existing Studies Continue, New Trials Have Dried Up

More than one year into the conflict, pharma employees in Ukraine have made heroic efforts to maintain existing clinical studies – but what the country’s doctors and CROs really want is for international companies to start opening new trials again.

Ukraine with test tube
• Source: Shutterstock

More than one year on from Russia’s invasion, Ukraine is bloodied but unbowed – but its once-flourishing clinical trials environment has all but ground to a halt.

While fierce fighting between Ukraine’s army and Russian forces continues in the south and east of the nation, the rest of the country is trying to carry on as normally as possible, but sporadic rocket and drone attacks terrorize the capital, Kyiv, and other cities behind the frontlines

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D